ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.

IPA ImmunoPrecise Antibodies Ltd

1.26
-0.02 (-1.56%)
09 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
ImmunoPrecise Antibodies Ltd IPA NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
-0.02 -1.56% 1.26 17:51:39
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
1.26 1.26 1.32 1.26 1.28
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
28/3/202413:35BWInterSystems et BioStrand, filiale d’IPA, collaborent au..
28/3/202406:02BWInterSystems and IPA’s Subsidiary BioStrand Collaborate to..
20/3/202412:52BWIPA acquiert l'instrument Carterra LSA® pour améliorer la..
20/3/202406:02BWIPA Acquires the Carterra LSA® Instrument to Enhance..
14/3/202418:39BWIPA présente ses résultats financiers et les récents points..
14/3/202407:05BWIPA Reports Financial Results and Recent Business Highlights..
07/3/202414:24BWBioStrand, filiale d'IPA, annonce une avancée majeure dans..
07/3/202410:19EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
07/3/202406:02BWIPA’s subsidiary BioStrand Unveils Major Breakthrough in..
04/3/202415:50BWL'IPA publiera ses résultats financiers et les faits..
04/3/202407:01BWIPA to Report Financial Results and Recent Business..
23/2/202416:29EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
23/2/202416:26EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
15/2/202414:12EDGAR2Form 6-K/A - Report of foreign issuer [Rules 13a-16 and..
10/1/202412:53EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
10/1/202412:33EDGAR2Form SC 13G - Statement of acquisition of beneficial..
14/12/202314:08BWIPA présente ses résultats financiers et les récents points..
14/12/202307:48EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
14/12/202307:38EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
14/12/202307:03EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
14/12/202307:01BWIPA Reports Financial Results and Recent Business Highlights..
08/12/202320:57BWIPA annonce la clôture d'une offre publique d'actions..
08/12/202316:11EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
08/12/202316:00BWIPA Announces Closing of $1.265 Million Public Offering of..
07/12/202315:53EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
06/12/202316:19EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
06/12/202306:57EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
06/12/202306:00BWIPA annonce le prix des actions ordinaires de son émission..
06/12/202305:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
05/12/202319:22BWIPA annonce une proposition d'offre publique d'actions..
05/12/202315:35BWIPA Announces Proposed Public Offering of Common Shares
05/12/202315:02EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
27/11/202312:09BWImmunoPrecise Antibodies Ltd annonce des nominations clés au..
27/11/202307:31EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
27/11/202307:01BWImmunoPrecise Antibodies Ltd. Announces Key Board and Board..
16/11/202316:13EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
13/11/202313:09BWBioStrand® dévoile une approche révolutionnaire de la..
13/11/202307:50EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
13/11/202307:32BWBioStrand® Unveils a Revolutionary Approach to Biological..
25/10/202311:12BWBioStrand, filiale de l'IPA, fait le point sur LENSai™
25/10/202307:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
25/10/202307:01BWIPA’s Subsidiary, BioStrand, Provides an Update on LENSai™
23/10/202312:36BWIPA apporte une mise à jour sur sa stratégie de croissance..
23/10/202307:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
23/10/202307:01BWIPA Provides Update on Growth Strategy and Recent Share..
20/10/202313:56EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
26/9/202310:56EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
25/9/202315:46EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
19/9/202311:34BWImmunoPrecise Antibodies annonce le remplacement de son..
19/9/202307:02EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..

Su Consulta Reciente

Delayed Upgrade Clock